Assignee
BIOCRINE AB
SE·26 granted patents·13 pending applications·82 citations·filing 2006–2022
Top patents by PatentIndex Score
39 records- 0194US8030288B2Methods for identifying compounds for the treatment of type 1 diabetesBIOCRINE AB·Filed 2008·Granted Oct 4, 2011·21 cites·6 claims
- 0294US7381523B2Methods for identifying compounds for treating diabetes mellitusBIOCRINE AB·Filed 2006·Granted Jun 3, 2008·26 cites·2 claims
- 0391US8716241B2ApoIII and the treatment and diagnosis of diabetesBIOCRINE AB·Filed 2013·Granted May 6, 2014·11 cites·4 claims
- 0486US10338060B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2018·Granted Jul 2, 2019·1 cites·21 claims
- 0586US9744232B2Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2016·Granted Aug 29, 2017·2 cites·21 claims
- 0685US12584904B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2022·Granted Mar 24, 2026·0 cites·8 claims
- 0785US9353183B2Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2015·Granted May 31, 2016·2 cites·18 claims
- 0885US9169484B2ApoIII and the treatment and diagnosis of diabetesBIOCRINE AB·Filed 2014·Granted Oct 27, 2015·4 cites·9 claims
- 0979US10060935B2ApoIII and the treatment and diagnosis of diabetesBIOCRINE AB·Filed 2017·Granted Aug 28, 2018·1 cites·5 claims
- 1079US9463205B2Non-invasive in vivo imaging and methods for treating type I diabetesBIOCRINE AB·Filed 2014·Granted Oct 11, 2016·3 cites·6 claims
- 1179US9068973B2Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2013·Granted Jun 30, 2015·2 cites·10 claims
- 1276US11519902B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2019·Granted Dec 6, 2022·0 cites·19 claims
- 1376US10228364B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2017·Granted Mar 12, 2019·1 cites·14 claims
- 1475US2020300875A1ApoCIII and the Treatment and Diagnosis of DiabetesBIOCRINE AB·Filed 2020·Application pending·0 cites
- 1574US9462973B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2013·Granted Oct 11, 2016·4 cites·14 claims
- 1673US10207012B2Non-invasive in vivo imaging and methods for treating type I diabetesBIOCRINE AB·Filed 2016·Granted Feb 19, 2019·1 cites·12 claims
- 1773US9702867B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2016·Granted Jul 11, 2017·1 cites·17 claims
- 1872US9068971B2Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2013·Granted Jun 30, 2015·2 cites·10 claims
- 1971US11707490B2Methods and reagents for treating diabetesBIOCRINE AB·Filed 2019·Granted Jul 25, 2023·0 cites·20 claims
- 2071US2023111951A1Methods and reagents for treating diabetesBIOCRINE AB·Filed 2022·Application pending·0 cites
- 2169US10695425B2Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosisBIOCRINE AB·Filed 2018·Granted Jun 30, 2020·0 cites·8 claims
- 2268US2018348240A1ApoCIII and the Treatment and Diagnosis of DiabetesBIOCRINE AB·Filed 2018·Application pending·0 cites
- 2367US10226530B2Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2017·Granted Mar 12, 2019·0 cites·12 claims
- 2465US10493108B2Non-invasive in vivo imaging and methods for treating diabetesBIOCRINE AB·Filed 2018·Granted Dec 3, 2019·0 cites·6 claims
- 2563US2020061121A1Non-invasive in vivo imaging and methods for treating type I diabetesBIOCRINE AB·Filed 2019·Application pending·0 cites
- 2662US2009060843A1Non-Invasive In Vivo Imaging and Methods for Treating Type I DiabetesBIOCRINE AB·Filed 2008·Application pending·0 cites
- 2760US7855049B2Inositol pyrophosphates determine exocytotic capacityBIOCRINE AB·Filed 2008·Granted Dec 21, 2010·0 cites·13 claims
- 2860US2016041191A1ApoIII and the Treatment and Diagnosis of DiabetesBIOCRINE AB·Filed 2015·Application pending·0 cites
- 2959US2015105436A1Methods and Assays for Detecting and Treating HypoglycemiaBIOCRINE AB·Filed 2014·Application pending·0 cites
- 3057US9968675B2Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosisBIOCRINE AB·Filed 2017·Granted May 15, 2018·0 cites·19 claims
- 3156US2015259416A1Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2014·Application pending·0 cites
- 3255US8021853B2Inhibition of the β3 subunit of L-type Ca2+ channelsBIOCRINE AB·Filed 2006·Granted Sep 20, 2011·0 cites·8 claims
- 3354US9700617B2Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosisBIOCRINE AB·Filed 2016·Granted Jul 11, 2017·0 cites·12 claims
- 3454US2017037118A1Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2016·Application pending·0 cites
- 3553US2016069866A1Inhibition of the beta3 subunit of l-type ca2+ channelsBIOCRINE AB·Filed 2015·Application pending·0 cites
- 3652US2014134660A1Inhibition of the beta3 subunit of l-type ca2+ channelsBIOCRINE AB·Filed 2013·Application pending·0 cites
- 3751US7601687B2Mechanism for identifying drugs for the treatment of type II diabetesBIOCRINE AB·Filed 2006·Granted Oct 13, 2009·0 cites·11 claims
- 3850US2024207325A1Pancreatic Islets as Protein FactoriesBIOCRINE AB·Filed 2022·Application pending·0 cites
- 3945US2011092577A1Inositol Pyrophosphates Determine Exocytotic CapacityBIOCRINE AB·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIOCRINE AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →